Miura Partners has invested in Saesco Medical, enhancing its market presence through the acquisition of Cardiolink, a specialized medical device distributor.
Target Information
Miura Partners has made a strategic investment in Saesco Medical, a leading European distributor based in Barcelona that focuses on innovative medical devices and equipment for minimally invasive surgery. Established in 2009, Saesco operates in five European countries, including Spain, Belgium, the Netherlands, Italy, and Poland, offering over 600 specialized products aimed at both public and private healthcare providers. The company’s expansive portfolio includes a wide range of surgical solutions for critical therapeutic areas such as obesity, gynecology, urology, and general surgery.
The investment will allow Saesco Medical to further strengthen its market presence by acquiring Cardiolink, a medical distribution company founded in 2004 by Josep Gatell and Manuel Vidal. Cardiolink is recognized for its expertise in advanced medical technology and operates in the Spanish and Portuguese markets. The integration of Cardiolink will enhance Saesco's portfolio and expand its clinical and hospital sector reach, particularly in Iberia.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Spain
The medical device industry in Spain has been experiencing steady growth, driven by an increasing demand for advanced healthcare solutions. The country’s healthcare system is characterized by a mix of public and private providers, which creat
Similar Deals
Miura Partners → Centro Psicosanitario Galiani and Orientak
2025
Palex → Werfen's Medical Devices and Scientific Instrumentation Distribution businesses
2024
Investor group advised by Rigeto Unternehmerkapital → Leaseir Medical Light S.L.
2023
Miura Partners
invested in
Saesco Medical
in 2025
in a Other Private Equity deal
Disclosed details
Revenue: $54M